The Journal of Heart and Lung Transplantation
Volume 27, Issue 7 , Pages 746-752 , July 2008

Survival and Quality of Life in Patients With Cardiac Resynchronization Therapy for Severe Heart Failure and in Heart Transplant Recipients Within a Contemporary Heart Failure Management Program

  • Michael Becker, MD

      Affiliations

    • Department of Cardiology, RWTH Aachen University, Germany
    • ,
  • Nora Erdmann

      Affiliations

    • Department of Cardiology, RWTH Aachen University, Germany
    • ,
  • Emilia Stegemann, MD

      Affiliations

    • Department of Cardiology, RWTH Aachen University, Germany
    • ,
  • Dirk Benke, MD

      Affiliations

    • Department of Cardiology, RWTH Aachen University, Germany
    • ,
  • Patrick N. Schauerte, MD

      Affiliations

    • Department of Cardiology, RWTH Aachen University, Germany
    • ,
  • Wolfgang M. Schaefer, MD, PhD

      Affiliations

    • Department of Nuclear Medicine, RWTH Aachen University, Germany
    • ,
  • Ruediger Autschbach, MD

      Affiliations

    • Department of Cardiac and Thoracic Surgery, RWTH Aachen University, Germany.
    • ,
  • Malte Kelm, MD

      Affiliations

    • Department of Cardiology, RWTH Aachen University, Germany
    • ,
  • Karl-Christian Koch, MD

      Affiliations

    • Department of Cardiology, RWTH Aachen University, Germany
    • Corresponding Author InformationReprint requests: Karl-Christian Koch, MD, Department of Cardiology, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. Telephone: +49-241-80-80605. Fax: +49-241-80-82303.

Received 24 August 2007 ,Revised 5 January 2008 ,Accepted 27 March 2008.

References 

  1. Cleland JGF, Loh H, Windram J, Goode K, Clark AL. Threats, opportunities, and statins in the modern management of heart failure. Eur Heart J. 2006;27:641–643
  2. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429–1435
  3. Packer M, Coats AJ, Fowler MB, et al. Carvedilol prospective randomized cumulative survival study group Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651–1658
  4. McMurray JJ, Ostergren J, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting enzyme inhibitors: the CHARM-Added trial. Lancet. 2003;362:767–771
  5. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341:709–717
  6. Cleland JG, Louis AA, Rigbz AS, et al. Noninvasive home telemonitoring for patients with heart failure at high risk for recurrent admission and death. J Am Coll Cardiol. 2005;45:1654–1664
  7. McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for admission. J Am Coll Cardiol. 2004;44:810–819
  8. Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. JAMA. 2003;289:2685–2694
  9. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845–1853
  10. Cleland J, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–1549
  11. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–2150
  12. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–237
  13. Deng MC, DeMeester JM, Smits JM, Heinecke J, Scheld HH. Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. BMJ. 2000;321:540–545
  14. Grady KL. Quality of life after heart transplantation: are things really better?. Curr Opin Cardiol. 2003;18:129–135
  15. Bullinger M. German translation and psychometric testing of the SF-36 health survey; preliminary results from the IQOLA project (International quality of life assessment). Soc Sci Med. 1995;41:1359–1366
  16. Ware JE, Sherbourne CD. The MOS 36-item short form health survey (SF-36): I (Conceptual framework and item selection). Med Care. 1992;30:473–483
  17. Bland JM, Altman DG. Statistics notes: Cronbach's alpha. BMJ. 1997;314:572
  18. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model (Prediction of survival in heart failure). Circulation. 2006;113:1424–1433
  19. Ellert U, Bellach BM. Der SF-36 im Bundes-Gesundheitssurvey-Beschreibung einer aktuellen Normstichprobe. Gesundheitswesen. 1999;61(suppl 2):S184–S190
  20. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report—2005. J Heart Lung Transplant. 2005;24:945–955
  21. Jimenez J, Benett Edwards L, Higgins R, et al. Should stable UNOS 2 patients be transplanted?. J Heart Lung Transplant. 2005;24:178–183
  22. Butler J, Khadim G, Paul KM, et al. Selection of patients for heart transplantation in the current ear of heart failure therapy. J Am Coll Cardiol. 2004;43:787–793
  23. Vanderheyden M, Wellens F, Bartunek J, et al. Cardiac resynchronization therapy delays heart transplantation in patients with end-stage heart failure and mechanical dyssynchrony. J Heart Lung Transplant. 2006;25:447–453
  24. Hummel M, Michauk I, Hetzer R, Fuhrmann B. Quality of life after heart and heart–lung transplantation. Transplant Proc. 2001;33:3546–3548
  25. Politi P, Piccinelli M, Poli PF, et al. Ten years of extended life: quality of life among heart transplantation survivors. Transplantation. 2004;78:257–263
  26. Mandak JS, Aaronson KD, Mancini DM. Serial assessment of exercise capacity after heart transplantation. J Heart Lung Transplant. 1995;14:468–478
  27. Krakauer H, Lin MJ, Bailey RC. Projected survival benefit as criterion for listing and organ allocation in heart transplantation. J Heart Lung Transplant. 2005;24:680–690

PII: S1053-2498(08)00286-6

doi: 10.1016/j.healun.2008.03.024

The Journal of Heart and Lung Transplantation
Volume 27, Issue 7 , Pages 746-752 , July 2008

Article Tools

* Image Usage & Resolution